USFDA completes Inspection at Solara Active Pharma Science’s manufacturing facility

28 Jan 2019 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Solara Active Pharma Science’s manufacturing facility in Ambernath, in the state of Maharashtra with zero 483s inspectional observations. The company stays committed to demonstrating the highest level of compliance with yet another USFDA audit with ‘Zero 483s’.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.